Authors
Latest:
Detecting Signs of Opioid Abuse and Treating the AddictionKnowing the warning signs and establishing trust are crucial to identifying and treating the opioid abuser.
Latest:
Systemic Therapy Options for Treating HR+/HER2– Metastatic Breast CancerFollowing initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).
Latest:
Trends in Statin Treatment Costs and Potential Impact of Novel TherapiesGeneric atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Latest:
Fostering Rapid Innovation During a Time of CrisisPromoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
Latest:
Implications of STeP for Improved Diabetes Control: A Payer PerspectiveImplementation of the STeP program across managed care organizations could lead to improved patient outcomes and significant cost savings.
Latest:
Manufacturer Reimbursement Support Programs Raise Legal Questions For Specialty PharmaciesNavigating insurance coverage for specialty drugs has always been a complex and fundamental part of the specialty drug distribution chain.
Latest:
Rheumatoid Arthritis and Joint Replacement: Impact of BiologicsSince the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.
Latest:
Pursuing a Path With the FDAAs a pharmacy student in Washington DC, I have had the privilege of being exposed to a number of opportunities available for pharmacists who wish to work in the federal government.
Latest:
New-Generation CephalosporinsSince their discovery in the 1950s, cephalosporins have become one of the largest classes of antibiotics.
Latest:
Type 3 Diabetes: An Alias for Alzheimer's Disease?Impairment in insulin and insulin growth factor seems to play a role in the development of Alzheimer's disease.
Latest:
Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition InteractionsThis study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
Latest:
Patient Engagement and Wellness: A Critical Piece of the Puzzle as Health Care Moves to Value-Based ModelsAlthough we have seen some progress through the proliferation of patient-centered medical homes, most clinicians have not fundamentally altered their basic approach to engaging with their patients.
Latest:
June 2023 Interactive Case StudiesCases highlight patients who have attention-deficity/hyperactivity disorder and diabetic peripheral nephropathy.
Latest:
Varicella-Zoster Virus: An Ounce of Prevention Does Not Equal a CureThe impact of varicella-zoster virus vaccination programs on the US population is not yet clear.
Latest:
Contact DermatitisContact dermatitis is among the most common inflammatory skin conditions encountered by clinicians.
Latest:
Utility of Antithrombotic Therapy in Chronic Systolic Heart FailureThe primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.
Latest:
Preventing Medication Errors in PharmacyHow to avoid common errors in pharmacies to protect patients.
Latest:
Medicare Part D Insulin Tiering Change: Impact on Health OutcomesThis study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Latest:
Annual Stroke Costs to Health Plans Among Atrial Fibrillation PatientsAn incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.
Latest:
Economic Burden of Oral Tyrosine Kinase Inhibitors Among Privately Insured Patients Diagnosed With Metastatic Renal Cell CarcinomaStudy investigate the economic burden from the total costs, private insurance reimbursement, and out-of-pocket costs for oral TKI agents among metastatic RCC patients.
Latest:
New Frontiers in Biosimilar PathwaysUS manufacturers prepare for expanding biosimilar market opportunities as this exciting landscape takes shape. The production of biosimilars poses challenges as pharma looks to curb health care spending.
